A left ventricular assist device (LVAD) is a surgically implanted pump that helps the left ventricle pump blood to the rest of the body. The purpose of this issue is to let cardiologists know about the latest devices, their complications, and the clinical situations in which they are most beneficial.
This issue of Cardiology Clinics, edited by Drs. Palak Shah and Jennifer Cowger, will focus on Mechanical Circulatory Support. Topics include, but are not limited to, The Evolution of Mechanical Circulatory Support, Continuous-flow Device Engineering and Pump Technology, Surgical Implantation: Perspective and Techniques, Temporary Circulatory Support and ECMO, Durable MCS Candidate Selection, Perioperative Management of the Right and Left Ventricle, Quality of Life, Frailty and Cognitive Impairment in the MCS Candidate, Microbiology and Infections in VAD recipients, Gastrointestinal Bleeding, Cerebrovascular Accident, Antithrombotic Strategies and Device Thrombosis, Impact of MCS on Post-Transplant Outcomes, Hemodynamic Pump-Patient Interactions & VAD Imaging, Ambulatory Patient Management, and Imaging in VAD recipients.
This issue of Cardiology Clinics will cover Right Ventricular Function and Failure. Curated by Drs. Jerry D. Estep and Miriam Jacob, this issue will explore topics in the field that are relevant for practicing clinicians. This issue is one of four selected each year by the series editorial board: Jamil A. Aboulhosn, David M. Shavelle, Terrence D. Welch, and Audrey H. Wu. The volume will include articles on: pathophysiology of acute and chronic right heart failure, right heart failure: a hemodynamic review, right heart failure causes and epidemiology, right heart failure and the cardiorenal syndrome, the role of multimodality imaging and RV failure, short term percutaneous mechanical circulatory support to treat acute right heart failure, defining and predicting right heart failure after LVAD placement, right heart failure after LVAD placement: medical and surgical management considerations, right heart failure in pulmonary hypertension, surgical and percutaneous interventions for chronic thromboembolic pulmonary hypertension, pulmonary hypertension and RV failure: lung transplant versus heart lung transplant, and RV failure and congenital heart disease.
Over 5.7 million people in America carry a diagnosis of heart failure, the incidence of which approaches 1 in 100 people over the age of 65. The cost to society is estimated at $29 billion annually and over 1.1 million hospital admissions. For hospitalized heart failure patients, the 30-day readmission rate approaches 25%. As our population ages these numbers are expected to grow. This issue of Cardiology Clinics helps practitioners to manage patients at all ACC/AHA stages of heart failure and addresses key issues that include sudden cardiac death, arrhythmias, acute decompensated heart failure, and heart failure with preserved ejection fraction.
Although heart failure typically begins with the left side of the heart, it is also important for cardiologists to understand right-sided heart failure, which is the inability of the right side of the heart to adequately pump venous blood into the pulmonary circulation. Right heart failure causes a back-up of fluid in the body, resulting in swelling and edema. This issue covers the normal right ventricle (RV), imaging of the RV, RV failure in a variety of settings, and tratmen tof RV failure, including interventions.
In this issue of Cardiology Clinics, guest editor Dr. Asad Ghafoor brings his considerable expertise to the topic of Heart Failure with Reduced Ejection Fraction. Top experts in the field cover issues such as choosing temporary mechanical support in cardiogenic shock; sequencing in quadruple therapy for HFrEF; the war against heart failure hospitalizations: remote monitoring and the case for expanding criteria; the uncertain benefit from ICDs in nonischemic cardiomyopathy; frailty and its spectrum of implications in HFrEF; and more. - Contains 12 relevant, practice-oriented topics including HFrEF and COVID-19: unmasking health inequities during a pandemic; our goals for prevention versus treating HFrEF with modern tech; the economic burden of HFrEF: living longer but poorer?; obesity in heart failure; the value of cardiopulmonary exercise testing in ambulatory HFrEF; and more. - Provides in-depth clinical reviews on heart failure with reduced ejection fraction, offering actionable insights for clinical practice. - Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Rotary blood pumps increasingly are being used in open heart surgery and in assisted circulation for patients with heart disease. These rotary devices include vortex (centrifugal) and axial pumps, which can be utilized in conditions where the use of conventional pulsatile pumps would entail problems of cost and size. Rapid progress is now being made in developing new devices for controlling blood flow within the heart and great vessels as well as extracorporeally for use in coronary and intensive care units and, in the future, for long-term use. This book provides information on the physiology of nonpulsatile circulation, the development of rotary pump engineering, and the clinical application of rotary blood pumps. It also presents an overview of future developments in this important field.
A significant medical event is expected in 1992: the first human use of a fully implantable, long-term cardiac assist device. This timely volume reviews the artificial heart program-and in particular, the National Institutes of Health's major investment-raising important questions. The volume includes: Consideration of the artificial heart versus heart transplantation and other approaches to treating end-stage heart disease, keeping in mind the different outcomes and costs of these treatments. A look at human issues, including the number of people who may require the artificial heart, patient quality of life, and other ethical and societal questions. Examination of how this technology's use can be targeted most appropriately. Attention to achieving access to this technology for all those who can benefit from it. The committee also offers three mechanisms to aid in allocating research and development funds.
This issue of Cardiology Clinics will cover Coronary Artery Disease. Curated by Dr. Alberto Polimeni, this issue will explore topics in the field that are relevant for practicing clinicians. This issue is one of four selected each year by the series editorial board: Jamil A. Aboulhosn, David M. Shavelle, Terrence D. Welch, and Audrey H. Wu. The volume will include articles on: High sensitivity troponins in acute coronary syndromes, High bleeding risk patient with CAD, Complete revascularization in chronic coronary syndrome, Patient selection for protected PCI, Clinical applications of echo strain imaging in coronary artery disease, Mechanical circulatory support for cardiogenic shock, Impact of NO donors on atherogenesis and atherosclerosis progression, Non-invasive Imaging risk stratification for CAD, Antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention, No-Reflow phenomenon, Coronary physiology assessment for the diagnosis and treatment of CAD, Bioresorbable coronary scaffold technologies, Non-coding RNAs in coronary artery disease, New advances in the treatment of severe coronary artery calcifications, and Refractory angina pectoris.
This issue of Interventional Cardiology Clinics reviews percutaneous circulatory support device use in several situations, including left and right ventricular shock, cardiopulmonary resuscitation, and infarct size reduction. Keep up to date with the latest developments in this rapidly evolving field.
